WENDY KAYS: Open Payments
NPI 1760932404 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,890 in 93 payments from 6 companies in 2025. Trend: 2023 $3,309 · 2024 $3,555 · 2025 $2,890
Food & beverage: $2,890
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 51 | $1,498 |
| Gilead Sciences, Inc. | 26 | $804 |
| Theratechnologies Inc. | 9 | $318 |
| Lilly USA, LLC | 2 | $136 |
| Merck Sharp & Dohme LLC | 4 | $113 |
| Napo Pharmaceuticals Inc | 1 | $22 |
Products named: DOVATO, APRETUDE, EGRIFTA, Yeztugo, MOUNJARO, PIFELTRO, CABENUVA, RUKOBIA.
Industry payments across FL — which companies pay providers there.
